人工智能和机器学习用于临床药理学.
David K Ryan1, Rory H Maclean1,2, Alfred Balston3
1Department of Clinical Pharmacology, University College London Hospitals NHS Foundation Trust, London, UK.
British journal of clinical pharmacology
|October 16, 2023
概括
人工智能 (AI) 在临床药理学方面取得了重大进展,影响了药物发现,试验和个性化医学. 临床药理学家必须了解并严格评估人工智能工具,以确保安全和公平的医疗整合.
科学领域:
- 临床药理学 临床药理学
- 医疗保健技术 医疗保健技术 医疗保健技术
- 人工智能的人工智能是人工智能.
背景情况:
- 人工智能 (AI) 在医疗保健领域正在迅速发展.
- 临床药理学包括药物发现,临床试验,个性化医学,药物基因组学,药物监测和临床毒理学.
- 了解人工智能对于临床药理学家来说至关重要.
研究的目的:
- 将临床药理学家介绍给AI.
- 突出目前在临床药理学中的AI应用.
- 讨论人工智能模型开发,评估和部署的挑战.
主要方法:
- 在临床药理学中审查当前的AI应用.
- 讨论AI模型开发过程.
- 对人工智能工具的评估和部署考虑的分析.
主要成果:
- 人工智能影响临床药理学的许多领域.
- 人工智能工具需要强大而严格的评估,以安全和公平地提高临床实践.
- 了解AI赋予临床药理学家领导其整合的权力.
结论:
- 临床药理学家需要了解人工智能,以便有效实施.
- 严格评估人工智能工具是必不可少的.
- 人工智能有可能以安全和公平的方式改变临床药理学实践.
更多相关视频
相关概念视频
Analysis of Population Pharmacokinetic Data
267
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
267
Structure-Activity Relationships and Drug Design
735
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
735
Mechanistic Models: Overview of Compartment Models
90
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
90
Pharmacokinetic Models: Comparison and Selection Criterion
79
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
79
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K


